3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon

Despite the significance of tumour neoangiogenesis and the extensive knowledge on the molecular basis of blood vessel formation currently no quantitative data exist on the 3D microvascular architecture in human primary tumours and their precursor lesions. This prompted us to examine the 3D vascular network of normal colon mucosa, adenomas and invasive carcinomas by means of quantitative microvascular corrosion casting. Fresh hemicolectomy specimens from 20 patients undergoing cancer or polyposis coli surgery were used for corrosion casting, factor VIII and VEGF immunostaining. In addition, immunostaining was done on colorectal tissue from 33 patients with metastatic and non-metastatic carcinomas, polyposis coli and adenomas. This first quantitative analysis of intervessel and interbranching distances, branching angles and vessel diameters in human cancer specimens revealed distinct patterns of the microvascular unit in the tumour centre and periphery. Irrespective of the tumour localization and grading all individual tumours displayed qualitatively and quantitatively the same vascular architecture. This gives further evidence for the existence of a tumour type-specific vascular architecture as recently demonstrated for experimental tumours. Metastatic tumours displayed different vascular architectures only within hot spots, in terms of smaller intervascular distances than in non-metastatic tumours. Pre-cancerous lesions have in part virtually the same vascular architecture like invasive carcinomas. Comparison of VEGF immunostaining also suggests that angiogenesis sets in long before the progress towards invasive phenotypes and that the so-called angiogenic switch is more likely a sequence of events. © 2001 Cancer Research Campaign

[1]  M A Konerding,et al.  Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts , 1999, British Journal of Cancer.

[2]  S. Maeda,et al.  K-ras gene mutation related to histological atypias in human colorectal adenomas. , 1995, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[3]  P. Carmeliet Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[4]  M A Konerding,et al.  Microvascular corrosion casting in the study of tumor vascularity: a review. , 1995, Scanning microscopy.

[5]  S. Leung,et al.  Vascular endothelial growth factor is up‐regulated in the early pre‐malignant stage of colorectal tumour progression , 1999, International journal of cancer.

[6]  R. Giavazzi,et al.  Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study. , 1998, The American journal of pathology.

[7]  J. Folkman,et al.  Blood Vessel Formation: What Is Its Molecular Basis? , 1996, Cell.

[8]  J. Folkman The vascularization of tumors. , 1976, Scientific American.

[9]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[10]  W. Clark,et al.  Biology of tumor progression in human melanocytes. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[11]  A. Ullrich,et al.  Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant , 1994, Nature.

[12]  J. Folkman,et al.  Vasculogenesis, Angiogenesis, and Growth Factors: Ephrins Enter the Fray at the Border , 1998, Cell.

[13]  P. Oehme,et al.  Demonstration of angiogenesis-activity in the corpus luteum of cattle. , 1977, Experimentelle Pathologie.

[14]  R. Kerbel,et al.  Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Smith-McCune,et al.  Demonstration and characterization of the angiogenic properties of cervical dysplasia. , 1994, Cancer research.

[16]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[17]  J. Folkman,et al.  Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Konerding,et al.  A simple and accurate method for 3-D measurements in microcorrosion casts illustrated with tumour vascularization. , 1995, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

[19]  J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[20]  W Blumenfeld,et al.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. , 1993, The American journal of pathology.

[21]  K. Haruma,et al.  Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  L. Ellis,et al.  p53, vessel count, and vascular endothelial growth factor expression in human colon cancer , 1998, International journal of cancer.

[23]  L. Ellis,et al.  Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. , 1997, Archives of surgery.

[24]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[25]  F Pozza,et al.  Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. , 1992, Journal of the National Cancer Institute.

[26]  A. Gaumann,et al.  MICROVASCULAR PATTERNS OF THE HUMAN LARGE INTESTINE: MORPHOMETRIC STUDIES OF VASCULAR PARAMETERS IN CORROSION CASTS , 1998 .